We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.0335 | 0.44% | 7.57 | 7.52 | 7.61 | 7.63 | 7.52 | 7.57 | 1,767,130 | 21:17:41 |
From May 2022 to May 2024
1415 GMT - Bayer is among the most-mentioned companies across news items over the past 12 hours, according to Factiva data, after it lifted its guidance for the full year and delivered a sales beat in the second quarter, despite posting a net loss. The German pharmaceutical-and-agricultural company said that sales rose to EUR12.82 billion for the quarter from EUR10.85 billion the year prior, beating consensus expectations which saw them at EUR12.29 billion. The company's quarterly net loss narrowed to EUR298 million from EUR2.34 billion the year prior, but said that earnings before interest and taxes were affected by net special charges of EUR2.11 billion including impairment losses related to its agricultural division. Bayer trades 2.6% lower at EUR57.28. Dow Jones & Co. owns Factiva. (cecilia.butini@wsj.com)
(END) Dow Jones Newswires
August 04, 2022 10:30 ET (14:30 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
